Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
elimination
health systems
people who inject drugs
viral hepatitis C
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
13
07
2018
revised:
22
08
2018
accepted:
24
08
2018
pubmed:
30
8
2018
medline:
9
1
2020
entrez:
30
8
2018
Statut:
ppublish
Résumé
The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of 39%, representing an estimated 6.1 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components: service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework.
Identifiants
pubmed: 30157316
doi: 10.1111/liv.13949
pmc: PMC6868526
mid: NIHMS987044
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
20-30Subventions
Organisme : Department of Health
ID : RP-PG-0616-20008
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R01 DA034086
Pays : United States
Organisme : Department of Health
ID : RP-DG-0610-10055
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA037773
Pays : United States
Informations de copyright
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
J Subst Abuse Treat. 2012 Dec;43(4):424-32
pubmed: 23036920
Int J Drug Policy. 2015 Oct;26(10):992-8
pubmed: 25697089
Clin Infect Dis. 2017 Apr 1;64(7):860-869
pubmed: 28362947
J Viral Hepat. 2012 Dec;19(12):836-42
pubmed: 23121361
Int J Drug Policy. 2015 Oct;26(10):999-1006
pubmed: 26275578
N Engl J Med. 2011 Jun 9;364(23):2199-207
pubmed: 21631316
J Clin Virol. 2014 Nov;61(3):359-64
pubmed: 25264306
Lancet Infect Dis. 2016 Dec;16(12):1409-1422
pubmed: 27615026
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
J Viral Hepat. 2014 May;21 Suppl 1:5-33
pubmed: 24713004
J Gen Intern Med. 2015 Jul;30(7):950-7
pubmed: 25680353
Clin Infect Dis. 2013 Aug;57 Suppl 2:S39-45
pubmed: 23884064
Drug Alcohol Depend. 2016 Dec 01;169:101-109
pubmed: 27810652
Clin Infect Dis. 2016 Dec 1;63(11):1405-1411
pubmed: 27553375
Ann Intern Med. 2017 May 2;166(9):637-648
pubmed: 28319996
Addiction. 2008 Sep;103(9):1484-92
pubmed: 18636999
J Clin Virol. 2012 Jul;54(3):213-7
pubmed: 22560051
Int J Drug Policy. 2015 Oct;26(10):922-35
pubmed: 26077144
Clin Infect Dis. 2013 Aug;57 Suppl 2:S32-8
pubmed: 23884063
Int J Drug Policy. 2015 Oct;26(10):984-91
pubmed: 26256938
Addiction. 2019 Jan;114(1):150-166
pubmed: 30035835
Dig Liver Dis. 2012 Jun;44(6):497-503
pubmed: 22342471
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):514-520
pubmed: 28442271
J Hepatol. 2017 Jan;66(1):153-194
pubmed: 27667367
Int J Drug Policy. 2015 Nov;26(11):1050-5
pubmed: 26118799
Addiction. 2018 Mar;113(3):545-563
pubmed: 28891267
Ann Intern Med. 2016 Nov 1;165(9):625-634
pubmed: 27537841
Int J Drug Policy. 2017 Sep;47:34-46
pubmed: 28797498
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161
pubmed: 29310928
Drug Alcohol Rev. 2002 Mar;21(1):33-7
pubmed: 12189002
J Infect Dis. 2011 Sep 15;204(6):825-31
pubmed: 21849279
Lancet. 2014 Nov 29;384(9958):1953-97
pubmed: 25433429
Clin Infect Dis. 2011 Oct;53(8):780-6
pubmed: 21921221
Clin Infect Dis. 2016 Mar 15;62(6):683-694
pubmed: 26787172
J Gastroenterol Hepatol. 2014 Jan;29(1):116-20
pubmed: 24033786
J Hepatol. 2018 Mar;68(3):402-411
pubmed: 29080808
Clin Infect Dis. 2013 Aug;57 Suppl 2:S56-61
pubmed: 23884067
J Public Health (Oxf). 2016 Mar;38(1):130-7
pubmed: 25736438
Hepatology. 2012 Jan;55(1):49-57
pubmed: 21898506
Clin Infect Dis. 2016 Dec 1;63(11):1479-1481
pubmed: 27553377
Harm Reduct J. 2008 Feb 25;5:8
pubmed: 18298862
J Health Care Poor Underserved. 2014 May;25(2):652-62
pubmed: 24858874
J Hepatol. 2011 Jun;54(6):1137-44
pubmed: 21145810
Croat Med J. 2016 Oct 31;57(5):442-456
pubmed: 27815935
PLoS One. 2014 Jul 28;9(7):e103345
pubmed: 25068274
J Clin Virol. 2017 Mar;88:46-51
pubmed: 28160728
Expert Rev Mol Diagn. 2017 Dec;17(12):1109-1115
pubmed: 29088981
J Hepatol. 2016 Jul;65(1):17-25
pubmed: 26867489
Addiction. 2011 May;106(5):970-6
pubmed: 21182552
J Viral Hepat. 2015 Jan;22 Suppl 1:6-25
pubmed: 25560839
Addiction. 2015 Jun;110(6):975-83
pubmed: 25586171
Int J Drug Policy. 2017 Sep;47:202-208
pubmed: 28619394
Hepatology. 2013 Nov;58(5):1598-609
pubmed: 23553643
J Infect. 2015 Nov;71(5):571-7
pubmed: 26212868
Clin Infect Dis. 2013 Aug;57 Suppl 2:S75-9
pubmed: 23884070
Clin Infect Dis. 2017 May 1;64(9):1154-1162
pubmed: 28199495
Am J Gastroenterol. 2006 Oct;101(10):2254-62
pubmed: 17032190
J Viral Hepat. 2015 Dec;22 Suppl 4:4-20
pubmed: 26513445
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):270-7
pubmed: 20425880
Addiction. 2012 Nov;107(11):1984-95
pubmed: 22564041
Clin Infect Dis. 2013 Apr;56(8):1078-84
pubmed: 23362288
Gut. 2003 Oct;52(10):1500-4
pubmed: 12970145
Educ Health (Abingdon). 2006 Nov;19(3):385-7
pubmed: 17178522
Clin Infect Dis. 2013 Aug;57 Suppl 2:S80-9
pubmed: 23884071
Br J Gen Pract. 2006 Nov;56(532):848-56
pubmed: 17132352
Am J Epidemiol. 2008 Nov 15;168(10):1099-109
pubmed: 18849303
J Viral Hepat. 2015 Apr;22(4):353-61
pubmed: 25367722
Am J Public Health. 2012 Nov;102(11):e115-21
pubmed: 22994166
Int J Drug Policy. 2017 Sep;47:51-60
pubmed: 28683982
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62
pubmed: 23817321
Hepatology. 2014 Dec;60(6):1861-70
pubmed: 25163856
Lancet. 2016 Sep 10;388(10049):1081-1088
pubmed: 27394647
Int J Drug Policy. 2015 Oct;26(10):1028-38
pubmed: 26282715
Am J Gastroenterol. 2016 Jun;111(6):903-5
pubmed: 27249993
Drug Alcohol Depend. 2016 Aug 01;165:53-60
pubmed: 27268294
Am J Gastroenterol. 2011 Oct;106(10):1777-86
pubmed: 21769136
J Clin Microbiol. 2017 May;55(5):1550-1556
pubmed: 28275079
Ann Intern Med. 2012 Oct 16;157(8):558-66
pubmed: 23070489
Euro Surveill. 2009 Apr 09;14(14):5-9
pubmed: 19371508
J Viral Hepat. 2017 Oct;24(10):850-857
pubmed: 28345206
J Community Health. 2014 Oct;39(5):922-34
pubmed: 25135842
J Viral Hepat. 2016 May;23(5):399-401
pubmed: 26833561
Drug Alcohol Depend. 2009 Jun 1;102(1-3):158-61
pubmed: 19251382
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):218-30
pubmed: 25782091
Clin Gastroenterol Hepatol. 2015 Nov;13(11):2005-14.e1-3
pubmed: 25724704
Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9
pubmed: 23884068
Open Forum Infect Dis. 2015 Oct 26;2(4):ofv162
pubmed: 26668814
Int J Drug Policy. 2014 Jan;25(1):34-52
pubmed: 23973009
Int J Drug Policy. 2015 Feb;26 Suppl 1:S5-11
pubmed: 25727260
Int J Drug Policy. 2007 Oct;18(5):406-10
pubmed: 17854729
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
J Telemed Telecare. 2017 Jan;23(1):83-87
pubmed: 26748393
World J Hepatol. 2016 Apr 18;8(11):509-12
pubmed: 27099651
Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145
pubmed: 21833948
J Viral Hepat. 2009 Feb;16(2):121-31
pubmed: 19175876
Health Policy Plan. 2014 Sep;29 Suppl 2:ii98-106
pubmed: 25274645
Am J Public Health. 2013 Oct;103(10):e81-8
pubmed: 23947319
J Infect Dis. 2016 Apr 1;213(7):1087-95
pubmed: 26333945
J Hepatol. 2016 May;64(5):1020-1026
pubmed: 26780289
Am J Public Health. 2011 Nov;101(11):2151-5
pubmed: 21940910
Clin Microbiol Infect. 2016 May;22(5):459.e1-6
pubmed: 26806260
Int J Drug Policy. 2017 Sep;47:209-215
pubmed: 28587943
J Viral Hepat. 2016 May;23(5):366-74
pubmed: 26840570
Addiction. 2018 Jan;113(1):173-182
pubmed: 28734093
Int J Drug Policy. 2017 Sep;47:216-220
pubmed: 28666635